7-Chloro-4-(piperazin-1-yl)quinoline → HCID 178502862, compound
Reaction equation
[Cl:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6]([N:12]3[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)=[CH:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1.[F:18][C:19]1[CH:24]=[CH:23][C:22]([NH:25][C:26]([NH:28][O:29][CH3:30])=S)=[CH:21][CH:20]=1.I([O-])(=O)(=O)=O.[Na+]>CN(C=O)C.O.O>[Cl:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6]([N:12]3[CH2:17][CH2:16][N:15]([C:26](=[N:28][O:29][CH3:30])[NH:25][C:22]4[CH:21]=[CH:20][C:19]([F:18])=[CH:24][CH:23]=4)[CH2:14][CH2:13]3)=[CH:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1Participants
6
Procedure
7-Chloro-4-(piperazin-1-yl)quinoline (297 mg, 1.2 mmol), N-(4-Fluorophenyl)-N′-methoxythiourea (240 mg, 1.2 mmol), and sodium periodate (278 mg, 1.3 mmol) in DMF-water 1:1 (40 mL) are heated at 85° C. for 1 h. The reaction mixture is diluted with water and extracted with ether. The organic phase is dried (MgSO4) and concentrated. The residue is purified by column chromatography with hexane-EtOAc yielding the title product.
Workup
- extractionextracted with ether
- dry with materialThe organic phase is dried (MgSO4)
- concentrationconcentrated
- customThe residue is purified by column chromatography with hexane-EtOAc yielding the title product
Sources & evidence
- ORD record
- ord-1a7ff1c4d8314b9d83859f37678ba419
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07220856B2
Reaction notes
Loading…